Cart (0)
Your shopping cart is empty!
Belosalik lotion spray 20 ml
Belosalik lotion spray 20 ml
Product Code: 537

Belosalik lotion spray 20 ml

Compare this Product
Release form

Solution for external use.

packaging 20 ml bottle with spray nozzle.

Pharmacological action

The drug is for external use. Belosalik® lotion has anti-inflammatory, antipruritic, decongestant, antiallergic, antiproliferative, immunosuppressive, keratolytic, antimicrobial, antifungal effects.

Betamethasone dipropionate is a synthetic GCS that has anti-inflammatory, anti-allergic, antipruritic and vasoconstrictive effects.

When applied to the surface of the skin, it constricts blood vessels, relieves itching, and reduces the release of inflammatory mediators (from eosinophils and mast cells), interleukins 1 and 2, gamma interferon (from lymphocytes and macrophages), inhibits the activity of hyaluronidase and reduces the permeability of the vascular wall.

Interacts with specific receptors in the cytoplasm of the cell, stimulates the synthesis of mRNA that induces the formation of proteins, including lipocortin, mediating cellular effects.

Lipocortin inhibits phospholipase A2, blocks the release of arachidonic acid and the biosynthesis of endoperoxides, prostaglandins, leukotrienes (contributing to the development of inflammation, allergies and other pathological processes).

Due to its keratolytic effect, salicylic acid cleanses the lesions from scales, promotes penetration of betamethasone into the skin, supports the acidic environment of the skin, preventing the development of bacterial and fungal infections.


Subacute and chronic dermatoses sensitive to GCS therapy and accompanied by hyperkeratosis and desquamation:



Seborrheic dermatitis (scalp).

Asbestos lichen.


lichen planus with localization on the scalp.


Dyshidrosis of the skin.



Tuberculosis of the skin.

Cutaneous manifestations of syphilis.

Chicken pox.

Viral skin infections.

Dermal post-vaccination reactions.

Open wounds.

Trophic ulcers.


Acne vulgaris.

Children under 6 months.

Hypersensitivity to betamethasone, salicylic acid, or to any of the auxiliary components of the drug.

Use during pregnancy and lactation

The use of Belosalik® Lotion in pregnant women is allowed in cases where the intended benefits to the mother outweigh the risk to the fetus.

In such cases, the use of the drug should be short-lived and limited to small areas of the skin.

During breastfeeding, the use of the drug Belosalik® Lotion is possible according to strict indications, but the drug should not be applied to the skin of the mammary gland before feeding.

Special instructions

The product is intended for external use only.

Avoid contact with eyes and mucous membranes, as well as the use of the drug in the anogenital region.

The use of the drug under an occlusive dressing is not recommended, unless necessary.

With the development of fungal or bacterial microflora on the skin, additional use of an antibacterial or antifungal agent is necessary.

The preparation BelosalikВ® lotion in the form of a solution for external use is especially suitable for use on the scalp. The solution is easily distributed on the surface of the skin, does not stick and does not dry hair, does not leave visible traces, It has a cooling effect on the skin.

Influence on the ability to drive vehicles and control mechanisms

Data on the adverse effects of the drug BelosalikВ® Lotion on the ability to drive vehicles and mechanisms are not available.

Composition of

1 g of solution contains:

Active substances:

betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg

salicylic acid - 20 mg.


disodium edetate - 0.3 mg,

hypromellose 4000 cps - 5 mg,

sodium hydroxide - 5 mg,

isopropanol - 392 mg,

water - 577.06 mg.

Dosage and administration

The drug is intended for external use.

A few drops of the solution for external use are evenly distributed over the surface of the skin, gently rubbing. Multiplicity of use - 2 times / day, in mild cases, single use is sufficient.

The duration of a continuous course of treatment is usually limited to 3-4 weeks. If a longer course of therapy is necessary, it is recommended to use the drug less often, for example, every other day.

The drug can be prescribed with caution to children from 6 months and for the shortest possible time.

Side effects

PoboNatural phenomena, as a rule, are reversible and have a mild character.

From the skin: it is possible to develop hypersensitivity reactions (itching, burning, hyperemia), acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, secondary skin infections.

With prolonged continuous uncontrolled use and when applied to large areas of the skin: telangiectasia, systemic manifestations of side effects of corticosteroids or salicylates.

If a hypersensitivity reaction or adverse reactions develops, the drug should be discontinued and consult a doctor.

Drug interaction

No clinically significant interaction with other drugs has been observed.

The simultaneous use of cosmetic and dermatological products for external use containing ethanol or a medical soap with a pronounced drying effect can cause skin irritation.


Symptoms: manifestation of systemic side effects.

Treatment: drug withdrawal and symptomatic therapy are recommended.

Storage conditions

Keep out of the reach and sight of children at temperatures not exceeding 25 РC.

Shelf life

2 years.

Deystvuyushtee substance

Betamethasone, Salitsilovaya Chisloth

dosage form

spray for external use



Nursing mothers as prescribed by the doctor, Children older than 6 months, Pregnant as prescribed Acha, for adults, children on doctor's prescription